Published in J Pediatr on March 01, 1990
Stability of dried blood spot specimens for detection of human immunodeficiency virus DNA by polymerase chain reaction. J Clin Microbiol (1992) 2.10
Rapid screening for early detection of mother-to-child transmission of human immunodeficiency virus type 1. J Clin Microbiol (1994) 1.68
Evaluation of the prototype Roche DNA amplification kit incorporating the new SSK145 and SKCC1B primers in detection of human immunodeficiency virus type 1 DNA in Zimbabwe. J Clin Microbiol (1999) 1.15
Stabilities of free and complexed human immunodeficiency virus p24 antigens during short- and long-term storage. J Clin Microbiol (1997) 1.05
Detection of human immunodeficiency virus type 1 (HIV-1) RNA in pools of sera negative for antibodies to HIV-1 and HIV-2. J Clin Microbiol (1998) 1.05
Laboratory methods for early detection of human immunodeficiency virus type 1 in newborns and infants. Clin Microbiol Rev (1992) 1.04
Detection of human immunodeficiency virus type 1 infection in young pediatric patients by using polymerase chain reaction and biotinylated probes. J Clin Microbiol (1992) 0.90
Enzyme immunoassay for detection of human immunodeficiency virus-specific immunoglobulin A antibodies. J Clin Microbiol (1993) 0.75
Early identification of human immunodeficiency virus infection in infants. J Pediatr (1991) 0.75
HIV antibody testing in children. Infectious Diseases and Immunization Committee, Canadian Paediatric Society. CMAJ (1993) 0.75
Indications for HIV testing in paediatric surgical patients. Malawi Med J (2005) 0.75
Ribonucleic acid synthesis of vesicular stomatitis virus, II. An RNA polymerase in the virion. Proc Natl Acad Sci U S A (1970) 11.83
Defective viral particles and viral disease processes. Nature (1970) 7.24
Comparative sedimentation coefficients of RNA extracted from plaque-forming and defective particles of vesicular stomatitis virus. J Mol Biol (1966) 6.61
Evolution and transmission of stable CTL escape mutations in HIV infection. Nature (2001) 6.57
Antiretroviral regimens in pregnancy and breast-feeding in Botswana. N Engl J Med (2010) 6.38
Defective T particles of vesicular stomatitis virus. I. Preparation, morphology, and some biologic properties. Virology (1966) 6.37
Ribonucleic acid synthesis of vesicular stomatitis virus. 3. Multiple complementary messenger RNA molecules. Virology (1970) 5.99
Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies. J Infect Dis (1985) 5.91
Ribonucleic acid synthesis of vesicular stomatitis virus. I. Species of ribonucleic acid found in Chinese hamster ovary cells infected with plaque-forming and defective particles. J Virol (1969) 5.73
Comparison of membrane protein glycopeptides of Sindbis virus and vesicular stomatitis virus. J Virol (1970) 4.54
Ribonucleic acid synthesis of vesicular stomatitis virus. IV. Transcription by standard virus in the presence of defective interfering particles. J Virol (1972) 4.48
The association of viral and bacterial respiratory infections with exacerbations of wheezing in young asthmatic children. J Pediatr (1973) 4.22
Defective interfering viruses. Annu Rev Microbiol (1973) 4.21
A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med (2000) 4.14
Soluble CD4 blocks the infectivity of diverse strains of HIV and SIV for T cells and monocytes but not for brain and muscle cells. Nature (1989) 3.54
Detection of respiratory syncytial virus in nasal secretions from infants by enzyme-linked immunosorbent assay. J Infect Dis (1979) 3.49
Defective T particles of vesicular stomatitis virus. II. Biologic role in homologous interference. Virology (1966) 3.49
Recovery in tracheal organ cultures of novel viruses from patients with respiratory disease. Proc Natl Acad Sci U S A (1967) 3.47
Ribonucleic acid polymerase in virions of Newcastle disease virus: comparison with the vesicular stomatitis virus polymerase. J Virol (1971) 3.34
Enzyme-linked immunosorbent assay for detection of respiratory syncytial virus infection: application to clinical samples. J Clin Microbiol (1982) 3.22
Initiation of polyribosome formation in poliovirus-infected HeLa cells. J Mol Biol (1970) 2.91
Platelet-derived growth factor and double-stranded ribonucleic acids stimulate expression of the same genes in 3T3 cells. Cell (1985) 2.82
The matrix (M) protein of vesicular stomatitis virus regulates transcription. Cell (1978) 2.81
Growth of pseudotypes of vesicular stomatitis virus with N-tropic murine leukemia virus coats in cells resistant to N-tropic viruses. J Virol (1973) 2.75
Coronavirus infection in acute lower respiratory tract disease of infants. J Infect Dis (1974) 2.55
Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1-infected women. Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (1999) 2.51
Absence of interference during high-multiplicity infection by clonally purified vesicular stomatitis virus. J Virol (1971) 2.48
RNA synthesis of vesicular stomatitis virus. V. Interactions between transcription and replication. J Virol (1973) 2.44
Viral pathogenesis and molecular biology. Bacteriol Rev (1977) 2.41
Inhibition of cellular RNA synthesis by nonreplicating vesicular stomatitis virus. Proc Natl Acad Sci U S A (1965) 2.37
The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis (1978) 2.32
Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med (2000) 2.31
Characterization of vesicular stomatitis virus nucleocapsids. I. Complementary 40 S RNA molecules in nucleocapsids. Virology (1974) 2.30
Concurrent circulation of antigenically distinct strains of respiratory syncytial virus during community outbreaks. J Infect Dis (1986) 2.26
Isopycnic separation of subcellular components from poliovirus-infected and normal HeLa cells. Science (1968) 2.25
Viral and bacterial infections in adults with chronic asthma. Am Rev Respir Dis (1979) 2.25
Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein. J Virol (1993) 2.21
Effects of phosphorylation and pH on the association of NS protein with vesicular stomatitis virus cores. J Virol (1978) 2.08
Cellular response to respiratory viruses with particular reference to children with disorders of cell-mediated immunity. J Pediatr (1980) 2.07
Coronaviridae: second report. Intervirology (1978) 2.05
Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr (1977) 2.00
Cardiac structure and function in children with human immunodeficiency virus infection treated with zidovudine. N Engl J Med (1992) 1.92
Interaction of HeLa cell proteins with RNA. J Mol Biol (1970) 1.90
Chlamydial infection of mothers and their infants. J Pediatr (1979) 1.89
Summary of a workshop on new and useful methods in viral diagnosis. J Infect Dis (1978) 1.87
Absence of cardiac toxicity of zidovudine in infants. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection Study Group. N Engl J Med (2000) 1.87
Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assay. J Virol (2000) 1.84
Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease. Proc Natl Acad Sci U S A (1967) 1.82
Role of infection in chronic bronchitis. Am Rev Respir Dis (1976) 1.81
Early detection of human immunodeficiency virus on dried blood spot specimens: sensitivity across serial specimens. Women and Infants Transmission Study Group. J Pediatr (1996) 1.79
Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children. J Virol (2000) 1.79
Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection. Infect Immun (1979) 1.70
Association of polyadenylic acid with messenger RNA of vesicular stomatitis virus. J Mol Biol (1973) 1.68
Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus. Virology (1966) 1.67
Seroepidemiologic studies of coronavirus infection in adults and children. Am J Epidemiol (1970) 1.66
Neonatal Haemophilus influenzae infection. Report of eight cases and review of the literature. Am J Dis Child (1975) 1.65
Cardiac morbidity and related mortality in children with HIV infection. JAMA (1993) 1.65
Bending-related faulting and mantle serpentinization at the Middle America trench. Nature (2003) 1.64
Interferon in nasal secretions from infants with viral respiratory tract infections. J Pediatr (1978) 1.61
Shedding of the glycoprotein from vesicular stomatitis virus-infected cells. J Virol (1978) 1.59
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58
Is it time to give influenza vaccine to healthy infants? N Engl J Med (2000) 1.58
Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial. Circulation (1994) 1.57
Coronaviridae. Intervirology (1975) 1.55
The formation of poliovirus proteins. Cold Spring Harb Symp Quant Biol (1969) 1.52
Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus. J Infect Dis (1988) 1.52
Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus. Prog Med Virol (1980) 1.51
Morphogenesis of avian infectious bronchitis virus and a related human virus (strain 229E). J Virol (1967) 1.49
The preparation and properties of adenovirus cores. J Gen Virol (1971) 1.49
Antigenic relationships among the coronaviruses of man and between human and animal coronaviruses. J Immunol (1969) 1.48
Phosphoproteins of vesicular stomatitis virus: identity and interconversion of phosphorylated forms. Virology (1979) 1.46
Reversible inhibition of interferon synthesis by puromycin: evidence for an interferon-specific messenger RNA. Proc Natl Acad Sci U S A (1965) 1.44
Phenotypic mixing between human immunodeficiency virus and vesicular stomatitis virus or herpes simplex virus. J Acquir Immune Defic Syndr (1990) 1.42
Isolation from man of "avian infectious bronchitis virus-like" viruses (coronaviruses) similar to 229E virus, with some epidemiological observations. J Infect Dis (1969) 1.41
Early diagnosis of HIV infection in infants by detection of IgA HIV antibodies. Lancet (1990) 1.41
Evaluation of human and simian immunodeficiency virus plaque and neutralization assays. J Gen Virol (1989) 1.39
Altered histopathology in protein-deprived mice during Sendai virus pneumonia: evidence for delayed inflammatory response and recovery. J Infect Dis (1992) 1.39
Prevalence of respiratory syncytial virus subgroups over six consecutive outbreaks: 1981-1987. J Infect Dis (1989) 1.39
Treatment of respiratory viral infection in an immunodeficient infant with ribavirin aerosol. Am J Dis Child (1984) 1.38
Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children. J Virol (2003) 1.38
A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants. J Virol (1999) 1.38
Mother-to-child transmission of HIV infection and CTL escape through HLA-A2-SLYNTVATL epitope sequence variation. Immunol Lett (2001) 1.37
Multicenter study of strains of respiratory syncytial virus. J Infect Dis (1991) 1.34
Distribution of phosphoserine, phosphothreonine and phosphotyrosine in proteins of vesicular stomatitis virus. Virology (1981) 1.34
Comparison of cynomolgus and rhesus monkey kidney cells for recovery of viruses from clinical specimens. J Clin Microbiol (1979) 1.33
Cardiovascular manifestations of human immunodeficiency virus infection in infants and children. Am J Cardiol (1989) 1.33
Synthesis and distribution of vesicular stomatitis virus-specific polypeptides in the absence of progeny production. Virology (1977) 1.31
Murine infection by vesicular stomatitis virus: initial characterization of the H-2d system. J Virol (1991) 1.30
Comparison of washed nasopharyngeal cells and whole nasal secretions for detection of respiratory syncytial virus antigens by enzyme-linked immunosorbent assay. J Clin Microbiol (1986) 1.28
Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay. J Infect Dis (1992) 1.27
Further characterization of the soluble form of the G glycoprotein of respiratory syncytial virus. J Virol (1988) 1.26
The association of rhinoviruses with lower respiratory tract disease in hospitalized patients. J Med Virol (1986) 1.23
Evaluation of a commercially available direct immunofluorescent staining reagent for the detection of respiratory syncytial virus in respiratory secretions. J Clin Microbiol (1986) 1.23
Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr (1993) 1.22
Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease. Nature (1986) 1.21